Opioid blocking medication naltrexone offered to released offenders in Vermont pilot program

November 30, 2015

Gov. Peter Shumlin announced a pilot program making naltrexone, a drug that prevents relapse in those undergoing treatment from opioid addiction, available to those being released from jail. Naltrexone's effects are similar to other opioid-blocking medications such as Suboxone and Methadone, however naltrexone is not an opioid. It only needs to be taken monthly via injection, not daily like Suboxone and Methadone. One must be completely free of opioids before taking the medication, otherwise it induces a withdrawal state. The program will begin in January and be available to those being released from the Marble Valley Correctional Facility in Rutland. Doctors across the state can already prescribe the medication, and it is covered by Medicaid, but this program, which will expand to other state correctional facilities, is designed to increase awareness and training for providers. The program is being funded by a $3-million Medication Assisted Treatment and Recovery grant from the HHS Substance Abuse and Mental Health Services Administration. The grant is for three years and will accommodate 350 people.
Related News:
Vermont launches opiate treatment program for newly released inmates - VPR